0001628280-19-009172.txt : 20190729
0001628280-19-009172.hdr.sgml : 20190729
20190729210134
ACCESSION NUMBER: 0001628280-19-009172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190729
FILED AS OF DATE: 20190729
DATE AS OF CHANGE: 20190729
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cozzens Todd C
CENTRAL INDEX KEY: 0001382487
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38993
FILM NUMBER: 19982990
MAIL ADDRESS:
STREET 1: ONE FEDERAL STREET
STREET 2: 25TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst, Inc.
CENTRAL INDEX KEY: 0001636422
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 453337483
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3165 E. MILLROCK, SUITE 400
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-708-6800
MAIL ADDRESS:
STREET 1: 3165 E. MILLROCK, SUITE 400
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: HQC Holdings, Inc.
DATE OF NAME CHANGE: 20150312
4
1
wf-form4_156444847869001.xml
FORM 4
X0306
4
2019-07-29
0
0001636422
Health Catalyst, Inc.
HCAT
0001382487
Cozzens Todd C
C/O HEALTH CATALYST, INC.
3165 MILLROCK DRIVE, #400
SALT LAKE CITY
UT
84121
1
0
0
0
Common Stock
2019-07-29
4
C
0
43967
0
A
134331
D
Common Stock
2019-07-29
4
C
0
6344
0
A
140675
I
By Matoaka, LLC
Common Stock
2019-07-29
4
C
0
943484
0
A
1084159
I
By Leerink Transformation Fund I, L. P.
Series C Preferred Stock
2019-07-29
4
C
0
43967
0
D
Common Stock
43967.0
0
D
Series D Preferred Stock
2019-07-29
4
C
0
6344
0
D
Common Stock
6344.0
0
D
Series E Preferred Stock
2019-07-29
4
C
0
943484
0
D
Common Stock
943484.0
0
D
Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares.
Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
The shares are held by Leerink Transformation Fund I, L.P. ("Leerink") and the Reporting Person is a co-founder and Managing Partner of Leerink and holds voting and dispositive power over the shares.
/s/ Daniel Orenstein, as Attorney-in-Fact
2019-07-29